Closing the Gap: Korean Holdcos Vs. Opcos
In this insight, we highlight the closing of the pricing gaps between the major Korean holdcos and opcos, especially with the upcoming end of the...
615 Views
KOSPI200 Index Rebalance: No Surprises Here, but Decent Impact Expected
There are 10 inclusions and exclusions in the KOSPI200 and there is significant impact expected some of the stocks. We feel the inclusions could...
635 Views
KOSPI200 Index Rebalance Preview: Review Period Nearly Complete, Nine (Or Ten) Possible Changes
The KOSPI200 index review will be announced in the next 4 weeks. We see 9 inclusions/ exclusions and significant volume to sell on the deletions....
606 Views
KOSPI200 Index Rebalance Preview: Adds Outperform Deletes; Short Sell Ban The Wildcard
The Korea Exchange (KRX) will announce the results of the December 2020 review of the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX) in...
655 Views
Celltrion Healthcare IPO Part 1 - Schedule, Financials & Valuation
Celltrion Healthcare (091990 KS), which is Celltrion Inc (068270 KS)’s overseas production distribution (sales) and marketing unit, just submitted...
906 Views